Table of Contents

Review Articles

• You have access

  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies

  Catherine A. Christian, Doodipala Samba Reddy, Jamie Maguire and Patrick A. Forcelli

  Lori L. Isom, ASSOCIATE EDITOR

  Pharmacological Reviews October 2020, 72 (4) 767-800; DOI: https://doi.org/10.1124/pr.119.017392
• Open Access

  On the Clinical Pharmacology of Reactive Oxygen Species

  Ana I. Casas, Cristian Nogales, Hermann A. M. Mucke, Alexandra Petraina, Antonio Cuadrado, Ana I. Rojo, Pietro Ghezzi, Vincent Jaquet, Fiona Augsburger, Francois Dufrasne, Jalal Soubhye, Soni Deshwal, Moises Di Sante, Nina Kaludercic, Fabio Di Lisa and Harald H. H. W. Schmidt

  Rhian M. Touyz, ASSOCIATE EDITOR

  Pharmacological Reviews October 2020, 72 (4) 801-828; DOI: https://doi.org/10.1124/pr.120.019422
• Open Access

  Is Oxytocin “Nature’s Medicine”?

  C. Sue Carter, William M. Kenkel, Evan L. MacLean, Steven R. Wilson, Allison M. Perkeybile, Jason R. Yee, Craig F. Ferris, Hossein P. Nazarloo, Stephen W. Porges, John M. Davis, Jessica J. Connelly and Marcy A. Kingsbury

  Robert Dantzer, ASSOCIATE EDITOR

  Pharmacological Reviews October 2020, 72 (4) 829-861; DOI: https://doi.org/10.1124/pr.120.019398
• 

  Open Access

  RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

  Ai-Ming Yu, Young Hee Choi and Mei-Juan Tu

  RHIAN M. TOUYZ, ASSOCIATE EDITOR

  Pharmacological Reviews October 2020, 72 (4) 862-898; DOI: https://doi.org/10.1124/pr.120.019554
• 

  You have access

  Development of Novel, Value-Based, Digital Endpoints for Clinical Trials: A Structured Approach Toward Fit-for-Purpose Validation

  M. D. Kruizinga, F. E. Stuurman, V. Exadaktylos, R. J. Doll, D. T. Stephenson, G. J. Groeneveld, G. J. A. Driessen and A. F. Cohen

  Martin Michel, ASSOCIATE EDITOR

  Pharmacological Reviews October 2020, 72 (4) 899-909; DOI: https://doi.org/10.1124/pr.120.000028